This company has been marked as potentially delisted and may not be actively trading. Bellicum Pharmaceuticals (BLCM) Short Interest Ratio & Short Volume Add Compare Share Share Short Interest Stock AnalysisBuy This Stock Bellicum Pharmaceuticals Short Interest DataBellicum Pharmaceuticals (BLCM) has a short interest of 809,200 shares. This marks a -43.81% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.3, indicating that it would take 0.3 days of the average trading volume of 22,874 shares to cover all short positions.Current Short Interest809,200 sharesPrevious Short Interest1,440,000 sharesChange Vs. Previous Month-43.81%Dollar Volume Sold Short$557,538.80Short Interest Ratio0.3 Days to CoverLast Record DateMay 31, 2023Outstanding Shares9,720,000 sharesPercentage of Shares Shorted8.33%Today's Trading Volume6,059 sharesAverage Trading Volume22,874 sharesToday's Volume Vs. Average26% Short Selling Bellicum Pharmaceuticals? Sign up to receive the latest short interest report for Bellicum Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartBLCM Short Interest Over TimeBLCM Days to Cover Over TimeBLCM Percentage of Float Shorted Over Time Bellicum Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/31/2023809,200 shares $557,538.80 -43.8%N/A0.3 $0.69 5/15/20231,440,000 shares $1.14 million +173.1%N/A0.5 $0.80 4/30/2023527,200 shares $184,520.00 +479.3%N/A0.2 $0.35 4/15/202391,000 shares $25,580.10 -15.8%1.1%0.1 $0.28 3/31/2023108,100 shares $35,673.00 +67.6%1.3%1.1 $0.33 3/15/202364,500 shares $27,657.60 -27.6%0.8%0.7 $0.43 2/28/202389,100 shares $80,457.30 +0.7%1.1%1.8 $0.90 2/15/202388,500 shares $108,412.50 -5.7%1.1%1.8 $1.23 1/31/202393,800 shares $106,932.00 +14.1%1.2%2.3 $1.14 1/15/202382,200 shares $80,967.00 -10.4%1.1%2.3 $0.99 Get the Latest News and Ratings for BLCM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Bellicum Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 12/30/202291,700 shares $66,024.00 -15.3%N/A3.7 $0.72 12/15/2022108,200 shares $91,970.00 -11.7%N/A5.7 $0.85 11/30/2022122,500 shares $127,400.00 -5.3%N/A9.2 $1.04 11/15/2022129,300 shares $138,351.00 -7.1%N/A9 $1.07 10/31/2022139,200 shares $147,552.00 +4.7%N/A8.4 $1.06 10/15/2022132,900 shares $131,265.33 +25.6%1.6%7 $0.99 9/30/2022105,800 shares $126,960.00 +62.8%1.3%5.6 $1.20 9/15/202265,000 shares $87,750.00 -24.0%0.8%3.2 $1.35 8/31/202285,500 shares $107,730.00 -13.8%1.0%3.9 $1.26 8/15/202299,200 shares $142,848.00 -34.0%1.2%3.8 $1.44 7/31/2022150,200 shares $190,258.34 +37.3%1.8%5.7 $1.27 7/15/2022109,400 shares $130,623.60 -33.7%1.3%4.2 $1.19 6/30/2022165,000 shares $196,350.00 +2.0%2.0%6.3 $1.19 6/15/2022161,700 shares $179,487.00 -3.8%1.9%5.8 $1.11 5/31/2022168,000 shares $236,880.00 -5.8%2.0%5.5 $1.41 5/15/2022178,400 shares $281,872.00 -10.9%2.1%6.2 $1.58 4/30/2022200,200 shares $312,312.00 -6.5%2.4%4.8 $1.56 4/15/2022214,100 shares $432,482.00 -8.1%2.6%4.2 $2.02 3/31/2022232,900 shares $503,064.00 -6.6%2.8%4.4 $2.16 3/15/2022249,400 shares $426,474.00 +8.8%3.0%3.4 $1.71 2/28/2022229,300 shares $389,810.00 -11.1%2.8%2.4 $1.70 2/15/2022257,800 shares $373,810.00 -40.2%3.1%2.5 $1.45 1/31/2022430,900 shares $702,367.00 +9.0%5.3%4 $1.63 1/15/2022395,400 shares $577,284.00 -14.1%4.8%3.2 $1.46 12/31/2021460,200 shares $685,698.00 -9.6%5.6%3.2 $1.49 12/15/2021509,100 shares $850,197.00 -8.0%6.1%3.7 $1.67 11/30/2021553,300 shares $962,742.00 -3.1%6.7%4 $1.74 11/15/2021571,000 shares $1.19 million -8.8%6.9%1.7 $2.08 10/29/2021626,200 shares $1.27 million -19.5%7.5%1.9 $2.03 10/15/2021777,700 shares $2.02 million -3.5%9.4%2.5 $2.60Buffett’s favorite chart just hit 209% – here’s what that means for gold (Ad)A Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the quiet buildup behind the scenes. Now, in just days, the floodgates are set to open. The greatest investor of all time is about to validate what Garrett Goggin has been saying for months: Gold is entering a once-in-a-generation mania. Front-running Buffett has never been more urgent — and four tiny miners could be your ticket to 100X gains.Be ready before the historic gold move. Get Garrett’s Top Four picks now. 9/30/2021806,100 shares $2.35 million -23.2%9.7%2.7 $2.92 9/15/20211,050,000 shares $3.14 million +51.5%12.6%3.5 $2.99 8/31/2021692,900 shares $2.10 million -12.6%8.3%2.3 $3.03 8/13/2021792,800 shares $2.34 million -7.3%9.5%7.6 $2.95 7/30/2021855,200 shares $2.56 million -7.1%10.3%6.9 $2.99 7/15/2021920,300 shares $2.76 million -10.7%11.1%6.5 $3.00 6/30/20211,030,000 shares $3.40 million -2.8%12.4%6.8 $3.30 6/15/20211,060,000 shares $3.23 million -1.9%12.7%5.8 $3.05 5/28/20211,080,000 shares $3.22 million -0.9%13.0%5.5 $2.98 5/14/20211,090,000 shares $3.20 million -0.9%13.1%4.5 $2.94 4/30/20211,100,000 shares $3.89 million +3.8%13.3%2.4 $3.54 4/15/20211,060,000 shares $3.72 million No Change12.8%1.6 $3.51 3/31/20211,060,000 shares $3.58 million +22.8%12.8%1.4 $3.38 3/15/2021863,000 shares $3.84 million +25.2%17.1%1.1 $4.45 2/26/2021689,100 shares $3.08 million +14.1%13.7%0.8 $4.47 2/12/2021603,900 shares $3.59 million +200.8%12.0%0.7 $5.94 1/29/2021200,800 shares $771,072.00 +24.0%4.1%0.3 $3.84 1/15/2021161,900 shares $615,220.00 -35.7%3.3%0.3 $3.80 12/31/2020251,900 shares $881,650.00 -14.0%5.1%0.6 $3.50 12/15/2020292,900 shares $922,635.00 -13.3%5.9%0.8 $3.15 11/30/2020337,800 shares $1.08 million -23.0%6.8%1.4 $3.19 11/15/2020438,500 shares $1.28 million +5.8%8.9%3.6 $2.91 10/30/2020414,500 shares $2.45 million -3.5%7.0%4.1 $5.90 10/15/2020429,500 shares $2.92 million -3.4%8.7%6.7 $6.79 9/30/2020444,600 shares $2.92 million +35.8%9.0%6.9 $6.57 9/15/2020327,500 shares $2.30 million -0.3%6.6%4.9 $7.03 8/31/2020328,400 shares $1.95 million -9.5%6.7%6.9 $5.95 8/14/2020362,800 shares $2.53 million -10.9%7.4%6.4 $6.98 7/31/2020407,100 shares $2.73 million -1.1%8.3%6.1 $6.71 7/15/2020411,500 shares $2.88 million -3.9%8.4%4.4 $6.99 6/30/2020428,200 shares $3.23 million +6.8%8.7%4.3 $7.54 6/15/2020401,100 shares $3.09 million +6.1%8.2%3.6 $7.70 5/29/2020378,200 shares $2.89 million +0.8%7.7%3.1 $7.63 5/15/2020375,100 shares $2.29 million -6.3%7.6%3.1 $6.11 BLCM Short Interest - Frequently Asked Questions What is Bellicum Pharmaceuticals' current short interest? Short interest is the volume of Bellicum Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of May 31st, traders have sold 809,200 shares of BLCM short. Learn More on Bellicum Pharmaceuticals' current short interest. Is Bellicum Pharmaceuticals' short interest increasing or decreasing? Bellicum Pharmaceuticals saw a decline in short interest in May. As of May 31st, there was short interest totaling 809,200 shares, a decline of 43.8% from the previous total of 1,440,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.00 billion), Suncor Energy Inc. ($2.98 billion), Charter Communications, Inc. ($2.88 billion), Occidental Petroleum Co. ($2.79 billion), Moderna, Inc. ($2.39 billion), Snowflake Inc. ($2.38 billion), Coinbase Global, Inc. ($2.22 billion), Palantir Technologies Inc. ($2.18 billion), T. Rowe Price Group, Inc. ($2.03 billion), and Verisk Analytics, Inc. ($2.02 billion). View all of the most shorted stocks. What does it mean to sell short Bellicum Pharmaceuticals stock? Short selling BLCM is an investing strategy that aims to generate trading profit from Bellicum Pharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Bellicum Pharmaceuticals? A short squeeze for Bellicum Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BLCM, which in turn drives the price of the stock up even further. How often is Bellicum Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BLCM, twice per month. The most recent reporting period available is May, 31 2023. More Short Interest Resources from MarketBeat Related Companies Apollomics Short Squeeze BriaCell Therapeutics Short Squeeze Cardio Diagnostics Short Squeeze CERo Therapeutics Short Squeeze Clene Short Squeeze Conduit Pharmaceuticals Short Squeeze enGene Short Squeeze Fortress Biotech Short Squeeze Immatics Short Squeeze Jasper Therapeutics Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BLCM) was last updated on 5/11/2025 by MarketBeat.com Staff From Our PartnersElon Warns “America Is Broke”. Trump’s Plan Inside.Elon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredVirtually Limitless Energy?A radical energy breakthrough could change everything. Scientists at MIT and a stealth startup may have discov...Stansberry Research | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bellicum Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bellicum Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BLCM Stock Free BLCM Stock Alerts